Molecular characterisation of group a Neisseria meningitidis isolated in Sudan 1985-2001

APMIS

Volumn 111, Issue 11, 2003, Pages 1060-1066

  Jacobsson, Susanne ^a   Issa, Mohamed ^b,c   Unemo, Magnus ^a   Bäckman, Anders ^a   Mölling, Paula ^a   Sulaiman, Nageeb ^b   Olcén, Per ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b National Health Laboratory Sudan   (Sudan)

^c UNIVERSITY OF JUBA   (Sudan)

Author keywords

Clonality; MLST; Neisseria meningitidis; PFGE; Sudan

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; PENICILLIN G; RIFAMPICIN; SULFADIAZINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLONAL VARIATION; GENOTYPE; NEISSERIA; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SUDAN;

ANTI-INFECTIVE AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SEROTYPING; SUDAN; SULFADIAZINE;

EID: 0346244033     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2003.apm1111108.x     Document Type: Article

References (24)

1. Greenwood B. Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 1999;93:341-53.
2. Popovic T, Sacchi CT, Reeves MW, Whitney AM, Mayer LW, Noble CA, et al. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg Infect Dis 2000;6:428-9.
3. Issa M, Mölling P, Unemo M, Bäckman A, Mosaad M, Sulaiman N, Olcén P. Neisseria meningitidis serogroup W-135 isolated from healthy carriers and patients in Sudan after the Hajj 2000. Scand J Infect Dis 2003;35:230-3.
4. World Health Organisation. Meningococcal disease, serogroup W135, Burkina Faso: Preliminary report, 2002. Wkly Epidemiol Rec 2002;77: 152-5.
5. Wang JF, Caugant DA, Li X, Hu X, Poolman JT, Crowe BA, Achtman M. Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun 1992;60:5267-82.
6. Olyhoek T, Crowe BA, Achtman M. Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983. Rev Infect Dis 1987;9:665-92.
7. Memish ZA. Meningococcal disease and travel. Clin Infect Dis 2002;34:84-90.
8. Salih MAM, Ahmed HS, Karrar ZA, Kamil I, Osman KA, Palmgren H, et al. Features of a large epidemic of group A meningococcal meningitis in Khartoum, Sudan in 1988. Scand J Infect Dis 1990;22:161-70.
9. Zhu P, van der Ende A, Falush D, Brieske N, Morelli G, Linz B, et al. Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc Natl Acad Sci USA 2001;98:5234-9.
10. Clarke SC, Diggle MA, Edwards GFS. Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis. J Clin Microbiol 2001;39:3066-71.
11. Mölling P, Unemo M, Bäckman A, Olcén P. Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases. APMIS 2000;108:509-16.
12. Mölling P, Bäckman A, Olcén P, Fredlund H. Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent Hajj pilgrimage. J Clin Microbiol 2001;39:2695-9.
13. Maiden MCJ, Bygraves J, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95:3140-5.
14. Enright MC, Spratt BG. Multilocus sequence typing. Trends Microbiol 1999;7: 482-7.
15. Yakubu DE, Abadi FJR, Pennington TH. Molecular typing methods for Neisseria meningitidis. J Med Microbiol 1999;48:1055-64.
16. Olcén P, Danielsson D, Kjellander J. The use of protein A-containing staphylococci sensitized with anti-meningococcal antibodies for grouping Neisseria meningitidis and demonstration of meningococcal antigen in cerebrospinal fluid. Acta path microbiol scand 1975;83:387-96.
17. Abdillahi H, Poolman JT. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987;48:367-71.
18. Hughes JH, Biedenbach DJ, Erwin ME, Jones RN. E test as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates. J Clin Microbiol 1993;31:3255-9.
19. Schoenknecht FD, Sabath LD, Thornsberry C. Susceptibility tests: special tests. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ Jr, editors. Manual of Clinical Microbiology, 4th ed. American Society for Microbiology, Washington, DC, 1985:1006.
20. Salih MAM, Danielsson D, Bäckman A, Caugant DA, Achtman, Olcén P. Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden. J Clin Microbiol 1990;28:1711-9.
21. Morelli G, Malorny B, Muller K, Seiler A, Wang JF, del Valle J. Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread. Mol Microbiol 1997;25:1047-64.
22. Nicolas P, Raphenon G, Guibourdenche M, Decousset L, Stor R, Gaye AB. The 1998 Senegal epidemic of meningitis was due to the clonal expansion of A:4:P2.9, clone III-1, sequence type 5 Neisseria meningitidis strains. J Clin Microbiol 2000;38:198-200.
23. Nicolas P, Décousset L, Riglet V, Castellt P, Stor R, Blannchet G. Clonal expansion of sequence type (ST-) 5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerg Infect Dis 2001; 7:849-54.
24. Gagneux S, Hodgson A, Ehrhard I, Morelli G, Genton B, Smith T, et al. Micro-heterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana. Trop Med Int Health 2000;5:280-7.